INDIANAPOLIS, Ind. (ADAMS) – A drug widely used to treat Type Two diabetes is on track to be approved for weight loss.
Eli Lilly, the company that makes Mounjaro, said today that FDA approval could come by the end of the year.
Studies have shown that obese people without diabetes on the drug have experienced weight loss as high as 21 percent.
Read more here
